Article
DNA damage signalling barrier, oxidative stress and treatment-relevant DNA repair factor alterations during progression of human prostate cancer.
Molecular oncology - 1 Jun 2016
Kurfurstova Daniela, Bartkova Jirina, Vrtel Radek, Mickova Alena, Burdova Alena, Majera Dusana, Mistrik Martin, Kral Milan, Santer Frederic R, Bouchal Jan, Bartek Jiri
Abstract excerpt
The DNA damage checkpoints provide an anti-cancer barrier in diverse tumour types, however this concept has remained unexplored in prostate cancer (CaP). Furthermore, targeting DNA repair defects by PARP1 inhibitors (PARPi) as a cancer treatment strategy is emerging yet requires suitable predictive biomarkers. To address these issues, we performed immunohistochemical analysis of multiple markers of DNA damage...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
